Australia markets open in 7 hours 48 minutes

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
63.83-3.35 (-4.98%)
As of 10:11AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close67.18
Bid64.99 x 800
Ask65.78 x 800
Day's range63.64 - 66.80
52-week range60.57 - 232.76
Avg. volume731,262
Market cap6.842B
Beta (5Y monthly)0.89
PE ratio (TTM)N/A
EPS (TTM)-0.27
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est119.33
  • Motley Fool

    Why Novocure Stock Is Jumping Today

    Shares of Novocure Limited (NASDAQ: NVCR) are jumping 12.9% higher as of 11:09 a.m. ET on Thursday. The solid gain came after investment firm Truist Financial upgraded the stock from a hold to a buy recommendation. Truist kept its 12-month price target for the stock at $125, which represents upside potential of more than 70%.

  • Business Wire

    Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update

    ST. HELIER, Jersey, January 10, 2022--Novocure today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2021.

  • Motley Fool

    3 Top Healthcare Stocks to Buy for January

    Healthcare can be a wonderful industry for investors. Telemedicine has been a big theme during COVID, especially during the height of lockdowns when patients were either frightened or at risk of infection, choosing instead to connect with healthcare providers digitally. Teladoc Health (NYSE: TDOC) has played a significant role in meeting this need and has grown rapidly as a result.